Dispensable role of CCL28 in Kras-mutated non-small cell lung cancer mouse models

被引：5
|
作者：
Lin, Dandan [1 ]
Zhang, Mengxin [2 ,3 ]
Guo, Hao [2 ,3 ]
Deng, Yu [4 ]
Zhong, Bo [2 ,3 ]
Liao, Fei [5 ]
Xu, Zhigao [6 ]
机构：
[1] Wuhan Univ, Renmin Hosp, Canc Ctr, Wuhan 430060, Peoples R China
[2] Wuhan Univ, Coll Life Sci, Dept Microbiol, Wuhan 430072, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Dept Gastrointestinal Surg, Dept Immunol,Med Res Inst, Wuhan 430071, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Thorac Surg, Tongji Hosp, Wuhan 430030, Peoples R China
[5] Wuhan Univ, Renmin Hosp, Gastroenterol Dept, Wuhan 430060, Peoples R China
[6] Wuhan Univ, Zhongnan Hosp, Dept Pathol, Wuhan 430071, Peoples R China
来源：
ACTA BIOCHIMICA ET BIOPHYSICA SINICA | 2020年 / 52卷 / 06期
关键词：
CHEMOKINE; BIOLOGY;
D O I：
10.1093/abbs/gmaa032
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：691 / 694
页数：4
相关论文
共 50 条
  • [31] Clinical Impact of Next-Generation Sequencing in KRAS-Mutated Non-Small Cell Lung Cancer Patients: a Single-Center Experience
    Anagnostakis, M.
    Panagiotou, E.
    Karachaliou, A.
    Kolintzikis, V.
    Tsamis, I.
    Vathiotis, I. A.
    Syrigos, N. K.
    Nikolaidou, V.
    Papafili, A.
    Kotteas, E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S485 - S485
  • [32] Clinical outcome of KRAS-mutated advanced non-small cell lung cancer (NSCLC) patients (pts): A mono-institutional analysis.
    Chiari, R.
    De Angelis, V.
    Bennati, C.
    Molica, C.
    Metro, G.
    Duranti, S.
    Tofanetti, F. R.
    Ludovini, V.
    Minotti, V.
    Crino, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer
    Fanini, Francesca
    Bandini, Erika
    Plousiou, Meropi
    Carloni, Silvia
    Wise, Petra
    Neviani, Paolo
    Murtadha, Mariam
    Foca, Flavia
    Fabbri, Francesco
    Vannini, Ivan
    Fabbri, Muller
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
  • [34] Prognostic Factors for Patients With KRAS Mutated Non-Small Cell Lung Cancer and Brain Metastases
    Tsakonas, G.
    Skribek, M.
    Kamali, C.
    Zerdes, I.
    Johannsdottir, B.
    Ekman, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S599 - S599
  • [35] The Diverse Analysis Identifies Mutated KRAS Associated With Radioresistance in Non-Small Cell Lung Cancer
    Zhu, Dao Qi
    Liu, Ying
    Yu, Zhi Jian
    Zhang, Ru Hua
    Li, Ai Wu
    Gong, Feng Ying
    Wang, Wei
    Xiao, Wei
    Fan, Qin
    WORLD JOURNAL OF ONCOLOGY, 2022, 13 (02) : 84 - 95
  • [36] The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer
    Nygaard, Anneli Dowler
    Spindler, Karen-Lise Garm
    Pallisgaard, Niels
    Andersen, Rikke Fredslund
    Jakobsen, Anders
    LUNG CANCER, 2013, 79 (03) : 312 - 317
  • [37] MicroRNAs: a new tool in the complex biology of KRAS mutated non-small cell lung cancer?
    Renaud, Stephane
    Seitlinger, Joseph
    Massard, Gilbert
    JOURNAL OF THORACIC DISEASE, 2017, 9 (04) : 957 - 960
  • [38] Targeting KRAS in Non-Small Cell Lung Cancer
    Corral de la Fuente, Elena
    Olmedo Garcia, Maria Eugenia
    Gomez Rueda, Ana
    Lage, Yolanda
    Garrido, Pilar
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [39] KRAS-mutated non-squamous non-small cell lung cancer. Comprehensive analysis of co-mutations and PDL1-expression
    Cristobal Redondo, V.
    Pedrero Castillo, V.
    Roca, R.
    Ortuno, S.
    Martinez-Banaclocha, N.
    Alenda Gonzalez, C.
    Aranda Lopez, I.
    VIRCHOWS ARCHIV, 2024, 485 : S131 - S131
  • [40] Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
    Rao, Ding-Yu
    Huang, De-Fa
    Si, Mao-Yan
    Lu, Hua
    Tang, Zhi-Xian
    Zhang, Zu-Xiong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345